Meru Health operates a digital mental health clinic built around a holistic mind-body program rather than a single intervention. Conventional care tends to isolate one modality, therapy sessions, a medication trial, or an app-based exercise course, and treats the rest as someone else’s problem. Meru combines licensed clinician support, structured therapeutic content, biofeedback, sleep and nutrition guidance, and peer groups into one longitudinal program, on the argument that outcomes in depression and anxiety improve when several inputs are addressed together.

The economics depend on measurement. Because the program is delivered digitally and tracks symptoms over time, Meru can report outcomes to the health plans and employers that pay for it, which is the difference between a wellness benefit and reimbursable care. Backed since 2020 and funded through a 38 million dollar Series B, the company sits in a deep-domain category where clinical evidence, licensure across jurisdictions, and payer contracts constitute the real barrier to entry. Demonstrated outcomes are what turn a pilot into a renewed contract, and that evidence accumulates with every cohort treated.